| Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis. |
Feb 2024 |
| Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data. |
Feb 2024 |
| Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding. |
Jan 2024 |
| Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis. |
Oct 2023 |
| Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode. |
Jul 2023 |
| Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. |
Jul 2023 |
| Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. |
Apr 2023 |
| Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. |
Oct 2022 |
| Non-invasive tests for clinically significant portal hypertension after HCV cure. |
Dec 2022 |
| Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event. |
Aug 2022 |
| Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. |
Oct 2022 |
| A novel machine learning-based radiomic model for diagnosing high bleeding risk esophageal varices in cirrhotic patients. |
Apr 2022 |
| Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis. |
Aug 2021 |
| Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data. |
Jan 2021 |
| Letter: improve survival! Place early pre-emptive TIPSS in high-risk variceal bleeders. |
Sep 2020 |
| Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. |
Nov 2020 |
| Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. |
Jun 2020 |
| Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study. |
Jan 2019 |
| Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. |
May 2018 |
| Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. |
Oct 2017 |
| TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise? |
Jan 2024 |
| Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD. |
May 2024 |
| Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: a post-hoc analysis of the PREDESCI trial. |
Sep 2024 |
| Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study. |
Sep 2024 |
| Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI. |
Jan 2025 |
| Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance. |
Mar 2025 |
| Future research direction of portal hypertension based on Baveno VII. |
Aug 2025 |
| Refining the Baveno VII criteria for clinically significant portal hypertension: an individual-patient data meta-analysis. |
Oct 2025 |
| Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD. |
Nov 2025 |
